Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

2003560 citationsJournal Article

Authors

Tjeerd van Staa · University of Southampton

Roland Laan · Radboud University Medical Center

I Barton · Procter & Gamble (United Kingdom)

Stanley Cohen

Donald Reid · University of Aberdeen

Cyrus Cooper · University of Southampton

Abstract

The daily, but not cumulative, GC dose was found to be a strong predictor of vertebral fracture in patients receiving GCs. At similar levels of BMD, postmenopausal women taking GCs, as compared with nonusers of GCs, had considerably higher risks of fracture.

Topics & Keywords

Bone health and osteoporosis research Bone Metabolism and Diseases Bone and Joint Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Arthritis & Rheumatism

Volume 48, Issue 11, pp. 3224-3229

DOI: 10.1002/art.11283

Field-Weighted Citation Impact: 17.50